HIRSCHMAN ORIN 13D and 13G filings for MEDICENNA THERAPEUTICS CORP:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | HIRSCHMAN ORIN | 4,672,075 6.700% | 242,092![]() (+5.46%) | Filing |
2023-02-15 06:35 am Purchase | 2022-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | HIRSCHMAN ORIN | 4,429,983 6.400% | 516,829![]() (+13.21%) | Filing |
2022-10-20 06:02 am Purchase | 2022-08-10 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | HIRSCHMAN ORIN | 3,913,154 5.600% | 3,913,154![]() (New Position) | Filing |